Sars -cov 2 epidemiology , therapy ,prevention
Authors: ilaria uccella
Date: 2020
Scope of interest: infectious disease training programs
06 99 39
Recup number
You may also be interested in:
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Authors: Giannini EG et al.
Date: 13 Nov 2023
Scope of interest: hepatological
Read details
Several impact of inflammatory markers on insulin resistance in the elderly.
Authors: Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafè M, Barbieri M, Corsi AM, Lauretani F, Franceschi C and Paolisso G
Date: 2004
Scope of interest: ageing, geriatrics
Read details
Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.
Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.
Date: 2020
Scope of interest: sars cov 2 therapy
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
